Drugs / verapamil extended-release capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07061574 | Mar 2026 → Apr 2030 expected | type 1 diabetes mellitus | City of Hope Medical Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | verapamil extended-release capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07061574 ↗ |
| Route | Oral | “Daily oral (pill) administration at 60, 120, 240 or 360 mg” NCT07061574 ↗ |